OmniaBio Inc. announces private investor
CCRM's manufacturing capabilities to go from clinical to commercial scaleHAMILTON, ON, May 31, 2022 /PRNewswire/ - OmniaBio Inc., a subsidiary of ...
Source: businessinsider.com
Stay updated with breaking news from Vector Production. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CCRM's manufacturing capabilities to go from clinical to commercial scaleHAMILTON, ON, May 31, 2022 /PRNewswire/ - OmniaBio Inc., a subsidiary of ...
/PRNewswire/ - OmniaBio Inc., a subsidiary of CCRM, has executed a strategic agreement with Medipost, a global leader in stem cell therapeutics. Medipost is...
/PRNewswire/ -- The global cell and gene therapy manufacturing market size is expected to reach USD 57.4 billion by 2028, according to a new report by Grand...